Red blood cell Cu/Zn superoxide dismutase activity in sporadic amyotrophic lateral sclerosis. 1994

J Puymirat, and L Cossette, and F Gosselin, and J P Bouchard
Department of Medicine and Molecular Genetics, CHU Laval, Sainte-Foy, Quebec, Canada.

To determine the possible role of Cu/Zn superoxide dismutase (SOD1) in the pathophysiology of sporadic amyotrophic lateral sclerosis (SALS), we measured SOD1 activity in red blood cell lysates in patients with SALS. SOD1 activity in red blood cell lysates was independent of age and sex in control patients, and no significant difference was found between the levels of SOD1 activity in controls (1174.8 +/- 213, n = 29) and SALS patients (1203.4 +/- 214, n = 27). These results suggest that point mutations in the SOD1 gene are apparently unrelated to SALS.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000690 Amyotrophic Lateral Sclerosis A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94) ALS - Amyotrophic Lateral Sclerosis,Lou Gehrig Disease,Motor Neuron Disease, Amyotrophic Lateral Sclerosis,Amyotrophic Lateral Sclerosis With Dementia,Amyotrophic Lateral Sclerosis, Guam Form,Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam,Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1,Charcot Disease,Dementia With Amyotrophic Lateral Sclerosis,Gehrig's Disease,Guam Disease,Guam Form of Amyotrophic Lateral Sclerosis,Lou Gehrig's Disease,Lou-Gehrigs Disease,ALS Amyotrophic Lateral Sclerosis,Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1,Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam,Disease, Guam,Disease, Lou-Gehrigs,Gehrig Disease,Gehrigs Disease,Sclerosis, Amyotrophic Lateral

Related Publications

J Puymirat, and L Cossette, and F Gosselin, and J P Bouchard
January 1994, Journal of neurochemistry,
J Puymirat, and L Cossette, and F Gosselin, and J P Bouchard
December 2006, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
J Puymirat, and L Cossette, and F Gosselin, and J P Bouchard
January 1999, Journal of the neurological sciences,
J Puymirat, and L Cossette, and F Gosselin, and J P Bouchard
October 1993, Lancet (London, England),
J Puymirat, and L Cossette, and F Gosselin, and J P Bouchard
November 1996, Journal of the neurological sciences,
J Puymirat, and L Cossette, and F Gosselin, and J P Bouchard
August 1993, Science (New York, N.Y.),
J Puymirat, and L Cossette, and F Gosselin, and J P Bouchard
January 2014, Prion,
J Puymirat, and L Cossette, and F Gosselin, and J P Bouchard
September 1994, Neuroscience letters,
J Puymirat, and L Cossette, and F Gosselin, and J P Bouchard
November 2019, Molecular neurodegeneration,
J Puymirat, and L Cossette, and F Gosselin, and J P Bouchard
February 1995, Experimental neurology,
Copied contents to your clipboard!